<DOC>
	<DOCNO>NCT00642356</DOCNO>
	<brief_summary>The purpose study test effect carbidopa/levodopa/entacapone compare effect immediate-release carbidopa/levodopa non-motor symptom end-of-dose wearing person Parkinson 's disease .</brief_summary>
	<brief_title>Carbidopa/Levodopa/Entacapone Versus Immediate Release ( IR ) Carbidopa/Levodopa Non-motor Symptoms Patients With Idiopathic Parkinson 's Disease Demonstrating Non-motor Symptoms Wearing Off</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Carbidopa</mesh_term>
	<mesh_term>Carbidopa , levodopa drug combination</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<mesh_term>Entacapone</mesh_term>
	<criteria>Be age 30 85 year . Be male female female patient must either childbearing potential ( define post menopausal least one year surgically incapable bear child ) , must practice contraceptive method outline protocol . Have clinical diagnosis idiopathic Parkinson 's Disease , exhibit least 2 3 symptom ( rigidity , rest tremor , bradykinesia ) Have nonmotor symptom end dose wear i.e. , presence least one nonmotor symptom Parkinson 's Disease improve next immediate release ( IR ) carbidopa/levodopa dose determined Quantitative WearingOff Questionnaire 9 investigator 's assessment . At least one nonmotor item show severity least 2 point ( maximum 4 ) show improvement least 1 one hour immediate release ( IR ) carbidopa/levodopa administration . Also deterioration 1 point another nonmotor item . ( criterion must fulfil ) Be take stable dose immediate release ( IR ) carbidopa/levodopa least 21 day prior randomization equivalent total daily dose immediate release ( IR ) carbidopa/levodopa 300 800 mg. Dosing either 3 6 time per day . Have previous history nonresponsive entacapone tolcapone treatment experience serious severe adverse event ( ) result discontinuation treatment previous use entacapone tolcapone ; current treatment entacapone tolcapone discontinue treatment either therapy discontinue less 60 day randomization ; Have history , sign , symptom suggest diagnosis secondary atypical parkinsonism ; Have unstable Parkinson 's Disease require frequent booster dos ; Disabling dyskinesia , indicate score great 1 Unified Parkinson Disease Rating Scale question # 32 , score great 1 Unified Parkinson Disease Rating Scale question # 33 ; Have history current diagnosis psychotic feature accord investigator ; Other protocoldefined inclusion/exclusion criterion apply study .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Idiopathic Parkinson 's disease</keyword>
	<keyword>carbidopa/levodopa/entacapone</keyword>
	<keyword>non-motor symptom</keyword>
	<keyword>motor-symptoms</keyword>
</DOC>